《大行》交银国际升云顶新耀(01952.HK)目标价至72.5元 维持“买入”评级。

阿斯达克财经
Jul 04, 2025

交银国际研究报告指,云顶新耀(01952.HK) 的AI+mRNA技术平台亮相研发日,集中展示基于该平台的数款mRNA肿瘤药物研发进展,包括1)EVM16已在小鼠模型中验证疗效,并与PD-1抗体有协同作用。IIT研究显示其低起始剂量也能激发患者特异性T细胞反应,免疫原性良好。2)EVM14临床前研究发现其具备诱导免疫记忆、降低肿瘤复发的潜力,正同步推进中美双报。3)自体生成CAR-T项目也已在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10